EQT

EQT is a global private equity and infrastructure firm founded in 1994, headquartered in Stockholm, Sweden. It specializes in buyouts, expansion capital, and infrastructure investments, focusing on mid-market companies with strong growth potential. EQT invests across various sectors, including healthcare, technology, services, industrials, and real estate, with a particular emphasis on Northern and Eastern Europe, Asia, and the US. The firm seeks to unlock growth potential in its portfolio companies, positioning them as sustainable market leaders, and typically holds investments for four to eight years. EQT also prioritizes ESG and impact investments in its infrastructure portfolio.

Sofia Ahuja

Partner

Christian Shin Høegh Andersen

Managing Director, Private Equity and Investment Advisory Professional

James Arrol

Managing Director, Fund Management

Teruyuki Asaoka

Managing Director

Fouad Azzam

General Partner

Peter Balslev

Managing Director

Johann-Christoph Balzer

Partner, EQT Value-Add Infrastructure

Eirik Benzon

Managing Director, BPEA EQT Team

William Bergström

Director

Lennart Blecher

Deputy Managing Partner

Clemens van Blitterswijk

Founder of LSP Health Economics Fund

Mark Braganza

Partner, Investment Advisory

Vincent Brichard

Venture Partner

Christoph Broja

Managing Director

Nicolas Brugere

Partner and Head of France

Anna Brundtland

Managing Director

Kenneth Cheong

Partner

Wonho Choi

Vice President

Henry Connon

Associate, Private Equity and Investment Advisory Professional

Crosby Cook

Partner, Infrastructure and Investment Advisory Professional

Guy Cui

Partner

Alex Darden

Partner, President and Head of EQT Infrastructure Advisory Team Americas

Rudy Dekeyser

Managing Partner, Health Economics Funds

Asis Echaniz

Partner and Head of Spain

Andreas Eichelberger

Director

Daan Ellens

Venture Partner

Frederik Elwing

Managing Director

Victor Englesson

Partner, Head of Private Equity Nordic and Co-Head of Global Technology Sector

Ali Farahani

Partner

Frank Feng

Managing Director

Andreas Fischer

Partner

Mark Fogle

Partner and Head of EQT Exeter APAC

David Forde

Partner

Juho Frilander

Managing Director

Joseph Fuda

Partner, Client Relations and Capital Raising

Florian Funk

Partner, Private Equity

Guillermo Garcia-Barrero

Managing Director

Henrik Giver

Managing Director

Simon Gold

Managing Director, Client Relations and Capital Raising

Wolfgang Gorny

Partner, Private Equity

Alexander Greenbaum

Partner, Active Core Infrastructure Advisory Team and Investment Advisory Professional

Fabian Grone

Partner, Infrastructure

Floris van Halder

Managing Director

Sean Ham

Partner and Head of Asia Pacific

Kevin Hammon

Associate

Jerry He

Partner and Head of China, Mid Market Asia Advisory Team

Frank Heckes

Partner, Private Equity

Jack Hennessy

Partner

Erika Henriksson

Partner, Private Equity

Jak Hestnes

Managing Director and Board Member

Gerran Ho

Managing Director, Mid Market Asia

Christian Horn

Managing Director

Sara Huda

Managing Director and Head of Investment Services

Johan Hylander

Managing Director

Bert Janssens

Head of Private Equity Europe and Global Co-Head of Services, Private Capital

Patrick Jaslowitzer

Managing Director

Neha Jatar

Managing Director

Yan Jiao

Partner

Herman Johre

Associate

Maarten de Jong

Partner, EQT Private Equity

Kosmo Kalliarekos

Partner

Viviana Kane

Managing Director

Masahiko Kato

Managing Director and Head of Infrastructure Japan

Matthew Kestenbaum

Managing Director

Nils Ketter

Partner

Gleb Kozyritskiy

Managing Director

Arvindh Kumar

Partner and Co-Head of Technology Sector Team

Elias Källström

Managing Director

Ulrich Kollensperger

Partner

Tobias Kung

Managing Director, Infrastructure

Priscilla Lam

Managing Director, Portfolio Monitoring

Lance Lan

Managing Director, Exit Management

Adam Larsson

Managing Director

Kenneth Lau

Associate

Edward Lavish

Managing Director, Portfolio Risk and Transactions

Alex Lee

Partner

Eu Han Lee

Partner, Debt Capital Markets

Hong Yong Leong

Partner

Janice Leow

Partner

William Lindström

Managing Director

Gebhard Littich

Managing Director

Eric Liu

Partner, Head of North American Private Equity and Co-Head of Global Healthcare Sector Team

Ashley Lundström

Partner

Nicholas Macksey

Partner

Madeleine Magnerius

Director

Paola Maleh

Partner and Head of EMEA

Francesco Malvezzi

Managing Director, Infrastructure

Tadashi Maruoka

Partner

Axel Masucci

Managing Director

Alastair Mitchell

Partner and Co-Head of EQT Ventures Advisory Team

Arnav Mitra

Director

Mikael Moll

Managing Director, Public Value

Maximilian Moser Ph.D

Vice President

Pascal Noel

Managing Director

Tetsuro Onitsuka

Partner and Head of Private Equity Japan

Alex Paganini

Associate, Infrastructure

Isabel De Paoli

Partner, Healthcare

Sydney Pardey

Managing Director

Tyler Parker

Managing Director

Daniel Perez

Partner

Christopher Popp

Managing Director

Shane Predeek

Partner

Thomas Rajzbaum

Managing Director and Partner, EQT Infrastructure

Hermann Rauch

Managing Director

Vera Rebanova

Partner, Client Relations and Capital Raising

Matthias Riefer

Managing Director, Private Equity

Niklas Ringby

Partner and Co-Head of Public Value Advisory Team

Patrick Rodden

Managing Director and Head of Infrastructure for Australia and New Zealand

Maxwell Roitstein

Associate

Joakim Rubin

Partner

Isidoor Rutten

Partner and Head of Private Equity Benelux

Rob Ryan

Managing Director, Market Risk

Darlene Sammon

Partner and Co-Head, Client Relations and Capital Raising

Carlos Santana

Partner, Private Equity

Anthony Santospirito

Partner

Mika Saukkonen

Managing Director, Infrastructure

Nirav Shah

Partner, EQT Value-Add Infrastructure

Hemant Sharma

Managing Director

Gordon Shaw

Partner

Piyush Singhvi

Managing Director, Infrastructure

Carl Sjölund

Partner, Infrastructure

Georg Stadler

Partner, Infrastructure

Francesco Starace

Partner

Dominik Stein

Partner and Head of EQT Growth Advisory Team

Joshua Stone

Managing Director, FO Head of Strategic Initiatives

Alexander Strassburger

Managing Director

Marc-Alexander Straubinger

Managing Director

Sang Jun Suh

Partner

Anna Sundell

Partner, Infrastructure

Miriam Tawil

Partner and Investment Advisory Professional

Michiel Thiessen

Managing Director

Elly Thio

Managing Director

Erwin Thompson

Partner, Infrastructure

Matteo Thun

Partner

Simon Tillmo

Director, Private Equity

Andrew Tirbeni

Managing Director, EQT Client Relations and Capital Raising

Wei Tor

Managing Director

Juan Vargas

Partner

Jan Vesely

Partner, Infrastructure

Marcus Wallinder

Partner and Deputy Head of Client Relations and Capital Raising

Forrest Wang

Managing Director, Private Equity

Ethan Waxman

Partner

Matthias Wittkowski

Partner

Ken Wong

Partner and Head of Asia Pacific, Infrastructure

Philipp Worner

Director, Private Equity

Shuting You

Managing Director

James Yu

Partner and Senior Bank Relationship Manager

Julia Zhu

Managing Director

John Österlund

Managing Director

Zoe Zhu

Director

Past deals in Ireland

Perfuze

Venture Round in 2025
Perfuze is a neurovascular medical device company based in Galway, Ireland, founded in 2018. The company focuses on developing innovative catheter technology specifically for the treatment of acute ischemic stroke. Perfuze aims to enhance clinical outcomes and reduce procedural times through its proprietary catheter-based aspiration technology, which optimizes the efficiency of clot removal. By simplifying procedures and minimizing the need for alternative treatment methods, Perfuze seeks to provide cost-effective solutions for patients suffering from ischemic stroke.

NUA Surgical

Series A in 2024
NUA Surgical is an award-winning startup based at the Innovation Hub in Galway, Ireland. The company has developed a patented surgical retractor designed to enhance the safety and efficiency of C-section procedures. NUA Surgical focuses on creating innovative medical devices for women's health, with a particular emphasis on improving outcomes for cesarean deliveries.

AMCS Group

Acquisition in 2024
AMCS Group is an Irish company headquartered in Limerick, specializing in integrated software and technology solutions for the waste, recycling, and resource management industries. Founded in 2002 by James Martin and Austin Ryan, AMCS offers a comprehensive range of products, including RFID technology, weighing systems, and ERP software, which facilitate efficient management of operations such as bin, vehicle, and skip management. The company’s platform is designed to standardize and optimize business processes, enabling clients to reduce operating costs, enhance asset utilization, and improve customer service. AMCS Group serves a diverse clientele, including municipalities, private recycling firms, and commercial waste haulers, helping them transition towards a circular economy for better resource management and logistics.

Perfuze

Series A in 2022
Perfuze is a neurovascular medical device company based in Galway, Ireland, founded in 2018. The company focuses on developing innovative catheter technology specifically for the treatment of acute ischemic stroke. Perfuze aims to enhance clinical outcomes and reduce procedural times through its proprietary catheter-based aspiration technology, which optimizes the efficiency of clot removal. By simplifying procedures and minimizing the need for alternative treatment methods, Perfuze seeks to provide cost-effective solutions for patients suffering from ischemic stroke.

Neurent Medical

Series B in 2021
Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015 by Brian Shields and David Townley. The company specializes in developing non-surgical treatments for inflammatory sino-nasal diseases, specifically focusing on chronic rhinitis. Neurent Medical offers a single-use, minimally invasive device designed for ENT surgeons, which utilizes a hand-held radio-frequency mechanism. This device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it deploys a microelectrode array to deliver targeted energy. This intervention interrupts the autonomic function of the mucosal structures in the nasal cavities, effectively reversing the inflammatory cascade. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs typically associated with traditional surgical procedures for rhinitis.

Cybin

Series B in 2020
Cybin is a biopharmaceutical company dedicated to advancing research and development in psychedelic and medicinal mushrooms. It focuses on creating safe and effective therapeutics for mental health issues, with an emphasis on psilocybin-based products. The company is actively launching these products in jurisdictions where they are permitted and is engaged in clinical studies across North America and other regions. Through strategic partnerships with academic and institutional entities, Cybin seeks to develop novel compounds and delivery mechanisms, aiming to provide innovative treatments for various psychiatric and neurological conditions.

Atlantic Therapeutics Limited

Series B in 2019
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

Dojo

Debt Financing in 2018
Dojo is a financial technology company that specializes in providing card payment solutions to small and medium-sized businesses in the UK and Ireland. The company offers a range of services, including contactless card machines, online payment systems, and integrated solutions, allowing over 100,000 businesses to accept payments in-store, online, via phone, and on the move. Founded in 2008 and based in London, Dojo focuses on delivering flexible and efficient payment processing options tailored to the needs of its clients. The company's offerings aim to enhance the payment experience for both merchants and their customers, thereby facilitating smoother transactions across various platforms.

Dojo

Debt Financing in 2016
Dojo is a financial technology company that specializes in providing card payment solutions to small and medium-sized businesses in the UK and Ireland. The company offers a range of services, including contactless card machines, online payment systems, and integrated solutions, allowing over 100,000 businesses to accept payments in-store, online, via phone, and on the move. Founded in 2008 and based in London, Dojo focuses on delivering flexible and efficient payment processing options tailored to the needs of its clients. The company's offerings aim to enhance the payment experience for both merchants and their customers, thereby facilitating smoother transactions across various platforms.

Vivasure Medical

Series C in 2016
Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.